About the Post-Conference Report
- There were 61 TPD abstracts presented at AACR. 51 were preclinical, including data for bivalent degraders, molecular glues and E3 modulators.
- This post-conference report lists abstracts grouped by preclinical and clinical data. Hyperlinks have been provided for the original abstract and the relevant Beacon pages.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements